CTLA4 and pancreatic neoplasm: We found higher expression levels of PDL1, not CTLA4, in the splenic dendritic cells of patients with PDAC, in agreement with findings made by Tjomsland et al. [35], who described high levels of PDL1 expression on blood dendritic cells in patients with pancreatic cancer, but not in those with chronic pancreatitis.